Eli Lilly drug slows Alzheimer’s progression by 35% in trial
An experimental Alzheimer’s drug developed by Eli Lilly and Co LLY.N slowed cognitive decline by 35% in a closely watched late-stage trial, the company said on Wednesday, raising hopes ...
Get the latest news and updates from around the world, with a focus on events that impact Cyprus and the international community. Our World section covers global politics, diplomacy, conflicts, economics, culture, and major international developments.